GSTM1 and myeloproliferative disorder: A more recent study on 158 patients with MDS/MPN-RS-T was based on the 2016 WHO criteria, in which abnormal karyotype (excluding -Y) and Hb ≤ 100 g/L were found to be independent predictors of survival [11].